D End

1.6k total citations
18 papers, 1.2k citations indexed

About

D End is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, D End has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in D End's work include Cancer-related Molecular Pathways (5 papers), Platelet Disorders and Treatments (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). D End is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Platelet Disorders and Treatments (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). D End collaborates with scholars based in United States, Cameroon and Belgium. D End's co-authors include Gordon Guroff, Karen Huff, Christine Toulas, Gilles Favre, Elizabeth Cohen–Jonathan, Caroline Delmas, Seiichi Hashimoto, N. Tolson, Philippe Müller and Patrick Angibaud and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

D End

18 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D End United States 16 744 401 173 164 161 18 1.2k
Tim P. Green United Kingdom 13 699 0.9× 504 1.3× 133 0.8× 55 0.3× 178 1.1× 14 1.2k
Richard I. Feldman United States 11 1.3k 1.8× 524 1.3× 209 1.2× 69 0.4× 138 0.9× 15 1.8k
David W. End United States 15 631 0.8× 301 0.8× 76 0.4× 128 0.8× 133 0.8× 26 1.1k
Kelli Glenn United States 13 895 1.2× 690 1.7× 124 0.7× 126 0.8× 182 1.1× 20 1.4k
Alastair J. King United States 18 1.6k 2.1× 659 1.6× 149 0.9× 98 0.6× 148 0.9× 28 2.0k
J. Paul Secrist United States 18 1.6k 2.1× 525 1.3× 93 0.5× 64 0.4× 161 1.0× 25 2.0k
R. Lyall United States 8 1.1k 1.5× 416 1.0× 79 0.5× 90 0.5× 63 0.4× 8 1.4k
Patrick A. Plé United Kingdom 17 877 1.2× 445 1.1× 109 0.6× 83 0.5× 572 3.6× 30 1.5k
Jacqueline S. Biscardi United States 9 1.3k 1.7× 917 2.3× 167 1.0× 86 0.5× 64 0.4× 11 1.9k
Rika Hoshino Japan 5 978 1.3× 361 0.9× 197 1.1× 59 0.4× 90 0.6× 7 1.2k

Countries citing papers authored by D End

Since Specialization
Citations

This map shows the geographic impact of D End's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D End with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D End more than expected).

Fields of papers citing papers by D End

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D End. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D End. The network helps show where D End may publish in the future.

Co-authorship network of co-authors of D End

This figure shows the co-authorship network connecting the top 25 collaborators of D End. A scholar is included among the top collaborators of D End based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D End. D End is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Molloy, Christopher J., et al.. (2008). Pharmacodynamics and Pharmacokinetics of the Novel Thrombopoietin Mimetic Peptide RWJ-800088 in Humans. Clinical Pharmacology & Therapeutics. 84(4). 481–487. 20 indexed citations
2.
3.
Saha, Ashis, Li Liu, Christophe Meyer, et al.. (2005). Novel triazole based inhibitors of Ras farnesyl transferase. Bioorganic & Medicinal Chemistry Letters. 15(24). 5407–5411. 22 indexed citations
4.
Brown, Kathryn H., Robert A. Harris, D End, et al.. (2005). Stimulation of Platelet Production in Healthy Volunteers by a Novel Pegylated Peptide-Based Thrombopoietin (TPO) Receptor Agonist.. Blood. 106(11). 1249–1249. 18 indexed citations
5.
Angibaud, Patrick, et al.. (2004). Synthesis Routes Towards the Farnesyl Protein Transferase Inhibitor ZARNESTRATM. European Journal of Organic Chemistry. 2004(3). 479–486. 110 indexed citations
6.
Delmas, Caroline, D End, Philippe Rochaix, et al.. (2003). The farnesyltransferase inhibitor R115777 reduces hypoxia and matrix metalloproteinase 2 expression in human glioma xenograft.. PubMed. 9(16 Pt 1). 6062–8. 60 indexed citations
7.
Delmas, Caroline, Elizabeth Cohen–Jonathan, D End, et al.. (2002). Farnesyltransferase inhibitor, R115777, reverses the resistance of human glioma cell lines to ionizing radiation. International Journal of Cancer. 100(1). 43–48. 77 indexed citations
8.
Kèlland, Lloyd R., Victoria Smith, Melanie Valenti, et al.. (2001). Preclinical antitumor activity and pharmacodynamic studies with the farnesyl protein transferase inhibitor R115777 in human breast cancer.. PubMed. 7(11). 3544–50. 79 indexed citations
9.
Zujewski, J., Ivan D. Horak, C.J. Bol, et al.. (2000). Phase I and Pharmacokinetic Study of Farnesyl Protein Transferase Inhibitor R115777 in Advanced Cancer. Journal of Clinical Oncology. 18(4). 927–927. 218 indexed citations
10.
Coster, R. De, Walter Wouters, R. Van Ginckel, et al.. (1992). Experimental studies with liarozole (R 75 251): An antitumoral agent which inhibits retinoic acid breakdown. The Journal of Steroid Biochemistry and Molecular Biology. 43(1-3). 197–201. 41 indexed citations
11.
End, D & Thomas Garrabrant. (1990). Characterization of a high affinity interleukin-1 (IL-1) specific binding site in a human synovial sarcoma (Hs431) cell line.. PubMed. 9(2). 167–76. 3 indexed citations
12.
Haigler, Harry T., D End, & E.S. Kempner. (1985). Molecular size of the epidermal growth factor receptor-kinase as determined by radiation inactivation.. Journal of Biological Chemistry. 260(4). 2178–2184. 9 indexed citations
13.
End, D, N. Tolson, Seiichi Hashimoto, & Gordon Guroff. (1983). Nerve growth factor-induced decrease in the cell-free phosphorylation of a soluble protein in PC12 cells.. Journal of Biological Chemistry. 258(10). 6549–6555. 50 indexed citations
14.
15.
Huff, Karen, D End, & Gordon Guroff. (1981). Nerve growth factor-induced alteration in the response of PC12 pheochromocytoma cells to epidermal growth factor. The Journal of Cell Biology. 88(1). 189–198. 233 indexed citations
16.
End, D, Richard A. Carchman, & William L. Dewey. (1981). Neurochemical correlates of chlordecone neurotoxicity. Journal of Toxicology and Environmental Health. 8(5-6). 707–718. 16 indexed citations
17.
Guroff, Gordon, P.C. Montgomery, N. Tolson, Michael E. Lewis, & D End. (1980). Induction of ornithine decarboxylase by renin-free nerve growth factor.. Proceedings of the National Academy of Sciences. 77(8). 4607–4609. 16 indexed citations
18.
Rubin, Ronald N., Suzanne G. Laychock, & D End. (1977). On the role of cyclic AMP and cyclic GMP in steroid production by bovine cortical cells. Biochimica et Biophysica Acta (BBA) - General Subjects. 496(2). 329–338. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tim P. Green Breakdown of academic impact, for papers by Richard I. Feldman Breakdown of academic impact, for papers by David W. End Breakdown of academic impact, for papers by Kelli Glenn Breakdown of academic impact, for papers by Alastair J. King Breakdown of academic impact, for papers by J. Paul Secrist Breakdown of academic impact, for papers by R. Lyall Breakdown of academic impact, for papers by Patrick A. Plé Breakdown of academic impact, for papers by Jacqueline S. Biscardi Breakdown of academic impact, for papers by Rika Hoshino
Rankless by CCL
2026